CIK 0001726445 · Non-accelerated filer<br>Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821153150
- Phone
- 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,809
- in 1 filing
Net −$14,809. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | FRIEDMAN CATHY Director | Grant or award · Stock Option (right to buy) | +29,640 | 29,640 | ||
| 2022-06-08 | Kogan Elona Esq. General Counsel and Secretary | Sale | −8,185 | $8.91 | $73K | 101,370 |
| 2022-05-27 | OSTADAN OMEAD President & COO | Sale | −4,441 | $8.06 | $36K | 378,238 |
| 2022-04-20 | OSTADAN OMEAD President & COO | Sale | −52,042 | $10.18 | $530K | 384,080 |
| 2022-03-21 | Thomas Scott D Chief Commercial Officer | Grant or award | +26,000 | 26,000 | ||
| 2022-03-21 | Thomas Scott D Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-03-02 | Nishar Dipchand Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-02-08 | Kogan Elona Esq. General Counsel and Secretary | Grant or award | +62,000 | 108,728 | ||
| 2022-02-08 | Kogan Elona Esq. General Counsel and Secretary | Grant or award · Employee Stock Option (right to buy) | +124,000 | 124,000 | ||
| 2022-02-08 | Horn David R. Chief Financial Officer | Grant or award | +62,000 | 291,158 | ||
| 2022-02-08 | Horn David R. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +124,000 | 124,000 | ||
| 2022-02-08 | OSTADAN OMEAD President & COO | Grant or award | +62,000 | 439,448 | ||
| 2022-02-08 | OSTADAN OMEAD President & COO | Grant or award · Employee Stock Option (right to buy) | +124,000 | 124,000 | ||
| 2022-02-08 | Farokhzad Omid CEO and Chair of the Board | Grant or award | +155,000 | 539,487 | ||
| 2022-02-08 | Farokhzad Omid CEO and Chair of the Board | Grant or award · Employee Stock Option (right to buy) | +73,425 | 73,425 | ||
| 2022-02-08 | Farokhzad Omid CEO and Chair of the Board | Grant or award · Employee Stock Option (right to buy) | +73,425 | 73,425 | ||
| 2022-02-08 | Farokhzad Omid CEO and Chair of the Board | Grant or award · Employee Stock Option (right to buy) | +73,425 | 73,425 | ||
| 2022-02-08 | Farokhzad Omid CEO and Chair of the Board | Grant or award · Employee Stock Option (right to buy) | +73,425 | 73,425 | ||
| 2022-02-02 | Horn David R. Chief Financial Officer | Sale | −2,944 | $17.40 | $51K | 229,158 |
| 2022-01-10 | LANGER ROBERT Director | Conversion | +327,102 | 692,459 |
Page 9 of 10 · 196 trades